Professor James is Professor of Clinical Oncology at the University of Birmingham and Consultant in Clinical Oncology at the Queen Elizabeth Hospital specialising in urological oncology.
He qualified in 1983 from St Bartholomew’s Hospital with the principal class prize in internal medicine. After general medical training in London and Brussels, oncology training was Bartholomew’s Hospitals and the Cancer Institute, Tokyo. He has been based in Birmingham since 1994.
Current research includes gene therapy for prostate cancer, clinical trials in urological tumours and information provision over the Internet. In 1994 he co-founded the leading patient website CancerHelp UK. Trials of the Birmingham-developed CTL102 adenovirus in prostate cancer have successfully completed phase I and the Phase II trial is now recruiting. In the urological clinical trials field, he is principal investigator on 3 current or forthcoming national phase III trials.